v3.25.1
STOCKHOLDERS' EQUITY AND EQUITY INCENTIVE PLANS (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Share-based Payment Arrangement, Activity

Number of Options
Weighted
Average exercise price
Weighted remaining contractual term (years)Aggregate
Intrinsic
Value








Outstanding as of January 1, 2025

16,321,014$3.29 4.34$5,212 


Granted

— $— 
Exercised

(1,252,550)$2.04 $445 
Forfeited

(693,151)$4.72 
Outstanding as of March 31, 2025

14,375,313$3.33 4.71$3,076 


Exercisable options at end of the period

14,370,625$3.33 4.71$3,076 
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity


RSUs
Outstanding

Weighted Average
Grant Date Fair
Value per Share
Outstanding as of January 1, 2025

12,331,745$1.56
RSUs granted

8,418,514$2.58
RSUs vested

(2,112,442)$1.69
RSUs forfeited (1)

(1,734,972)$1.52
Unvested and Outstanding as of March 31, 2025

16,902,845$2.05
Schedule of share-based compensation expense by line item
Three Months Ended March 31,
20252024
Cost of revenue$128 $285 
Research and development849 1,172 
Sales and marketing432 770 
General and administrative3,124 4,302 
Total expenses$4,533 $6,529 
Schedule Of Shares Of Common Stock Reserved For Future Issuance
March 31, 2025
Outstanding options14,375,313 
Outstanding RSUs16,902,845 
Shares reserved under 2021 Plan6,035,813 
Total37,313,971